Clinical trials
Dry Eye Syndromes trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
174 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 11 |
| 2017 | 6 |
| 2018 | 15 |
| 2019 | 9 |
| 2020 | 17 |
| 2021 | 26 |
| 2022 | 16 |
| 2023 | 26 |
| 2024 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 174 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| He Eye Hospital | 9 |
| National Taiwan University Hospital | 5 |
| Peking University Third Hospital | 5 |
| Bedford Hospital NHS Trust | 4 |
| Chang Gung Memorial Hospital | 4 |
| Meir Medical Center | 4 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 4 |
| Olympic Ophthalmics, Inc. | 3 |
| Far Eastern Memorial Hospital | 2 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 174 |
| Meibomian Gland Dysfunction | 19 |
| Cataract | 6 |
| Inflammation | 6 |
| Sjogren's Syndrome | 6 |
| Corneal Diseases | 5 |
| Keratoconjunctivitis Sicca | 4 |
| Xerophthalmia | 4 |
| Blepharitis | 3 |
| Diabetes Mellitus | 3 |
Trials
Showing 51 to 75 of 174. Each trial links to its page on Pharma Observatory.
74 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.